This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03878/identifier/chemspider/
n7http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n9http://linked.opendata.cz/resource/drugbank/drug/DB03878/identifier/pdb/
n4http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://linked.opendata.cz/resource/drugbank/drug/DB03878/identifier/pubchem-compound/
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n13http://linked.opendata.cz/resource/drugbank/drug/DB03878/identifier/pubchem-substance/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB03878/identifier/drugbank/

Statements

Subject Item
n2:DB03878
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB03878 n7:DB03878
dcterms:title
N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide
adms:identifier
n9:PRC n10:4327 n11:4174 n12:DB03878 n13:46505112
n5:IUPAC-Name
n6:271B4B64-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B4B6A-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B4B69-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B4B66-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B4B67-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B4B68-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B4B62-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B4B63-363D-11E5-9242-09173F13E4C5 n6:271B4B60-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B4B61-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B4B70-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B4B71-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B4B6B-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B4B6C-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B4B6E-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B4B6D-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B4B6F-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B4B76-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B4B78-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B4B79-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B4B75-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B4B74-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B4B77-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B4B65-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B4B72-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B4B73-363D-11E5-9242-09173F13E4C5